You are here
MEDCHEM PARTNERS LLC
UEI: S93ZFQLD4ZC7
# of Employees: 3
HUBZone Owned: No
Socially and Economically Disadvantaged: No
Woman Owned: Yes
Award Charts
Award Listing
-
STTR Phase I: Novel Inhaled Nitric Oxide Therapy For Pulmonary Treatments (COVID-19)
Amount: $256,000.00The broader impact /commercial potential of this Small Business Technology Transfer (STTR) Phase I project relates to the unmet need for new and effective therapeutics that target the lung. This propo ...
STTRPhase I2021National Science Foundation -
Dynasore Analogues for Ocular Surface Protection
Amount: $556,030.007. PROJECT SUMMARY Diseases of the ocular surface are among the top reasons for visits to eye care practitioners. These conditions can severely affect eyesight and quality of life. Symptoms may includ ...
STTRPhase I2019Department of Health and Human Services National Institutes of Health -
Drug containing hydrogels which release nitric oxide for diabetic wound healing
Amount: $151,753.00DESCRIPTION provided by applicant The goal of this Phase I proposal is to discover and develop compounds which can release a therapeutically relevant amount of nitric oxide in a controllable manner ...
SBIRPhase I2015Department of Health and Human Services National Institutes of Health -
A Novel Insulin Pathway Agonist for Alzheimer's Disease
Amount: $147,729.00DESCRIPTION (provided by applicant): Even though the association of -amyloid peptide (A ) deposition and Alzheimer's Disease (AD) underpins the major hypothesis for disease progression and possi ...
STTRPhase I2013Department of Health and Human Services National Institutes of Health -
SBIR Phase I:Ring Contraction Metathesis Reaction for the Generation of Novel Polyene Macrolides
Amount: $144,579.00This Small Business Innovation Research (SBIR) Phase I project will develop a process for modifying macrolide natural products in general and Rapamycin in particular using a relatively new chemical tr ...
SBIRPhase I2010National Science Foundation
